Press Releases
-
See How the New ClinOne Connects, Informs and Empowers Patients in Complex Clinical Trials at the SCOPE Summit for Clinical Ops Execs
At the SCOPE Summit (Feb 7-10, 2022), ClinOne will unveil its new brand, product marketecture, and messaging – and showcase how its mission to connect, inform and empower clinical trials patients is making it one of the fastest growing companies to watch in clinical technology.
Feb 6, 2022
-
DFE Pharma appoints Martti Hedman as new CEO
DFE Pharma appoints Martti Hedman as new CEO The combination of his experience, culture and drive makes him an ideal fit for DFE Pharma for the next stages of growth Goch, Germany (7th February 2022) – DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, today announced that Martti Hedman has been appointed as the new Chief Executive Officer. An experienced business leader, Hedman will succeed Bas van Driel and assume responsibilities on 14th February. Van Driel decided to step down in order to allow the company to further grow after setting the company up for success.
Feb 6, 2022
-
Rho Clinical Development Expert Available for One-on-one Discussions at the 14th Annual Outsourcing in Clinical Trials West Coast
Rho, a full-service contract research organization (CRO), is sharing its clinical development expertise with attendees of the 14th Annual Outsourcing in Clinical Trials (OCT) West Coast conference, taking place at the Hyatt Regency San Francisco Airport from February 15-16, 2022. Rho’s Associate Director of Business Development Brennan Munley is offering one-on-one meetings with those interested in learning more about how Rho can help ensure an efficient and a successful drug development process.
Feb 7, 2022
-
PharmiWeb Launches New US-Focused Life Science Job Board
A new Life Science and Clinical Research Job Board in the USA.
Feb 7, 2022
-
Curebase Joins the SCRS Global Impact Partner Program
Curebase Joins the SCRS Global Impact Partner Program
Feb 7, 2022
-
CD Formulation Provides Tailor-made Solutions for Thickener Excipients for Drug Development
-
A Triplet Breakthrough for Novel Concepts Medical: Stopped COVID-19, the Omicron Variant, and Long COVID-19 Symptoms, Including Memory Loss
Novel Concepts Medical announces another major breakthrough in its research of COVID-19.
Feb 8, 2022
-
RealTime-CTMS Introduces a Powerful, No-Cost Custom Reporting Tool Into All CTMS Products
RealTime Software Solutions, LLC has released the inSITES Report Builder, a powerful custom reporting tool built into RealTime’s leading Clinical Trial Management System (CTMS) that now allows all customers, at no additional charge, to build and save their own customized reports to monitor site-wide performance and maximize efficiencies and outcomes.
Feb 8, 2022
-
LogiPharma leads the way as Tower takes cold chain containers on the road
About Tower www.towercoldchain.com Tower delivers proven physical and temperature protection for pharmaceutical and life science products and our robust, reliable and reusable containers are the essential link in the stability of the cold chain. Headquartered in the UK, we operate a global network ensuring availability and easy access to our products for all customers. We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralised quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain. Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world. We work closely with our customers, realising their requirements and how we can address emerging needs. and to deliver customer-focused innovation in temperature-controlled protection. For Tower sales enquiries please contact: Nick Gilmore, Global Head of Sales & Marketing Email: Nick.Gilmore@towercoldchain.com For Tower media enquiries please contact: Simon Kinnear or Rhiannon Hopper, Nielsen McAllister Tel: +44 (0)1332 293939 Email: tower@nmpr.co.uk
Jan 30, 2022
-
INCOG BioPharma Services builds state-of-the-art facility with promise to deliver a better customer experience
-
ArisGlobal Closes 2021 with Tremendous Growth Across Customer Base, Talent, and Revenue, Further Solidifying Its Leadership in Life Sciences R&D Software
Life sciences technology pioneer delivers record bookings and double-digit increase in revenue; Gears up for the future with investments in LifeSphere SaaS platform
Jan 12, 2022
-
BOC Sciences Provides PseudoUridines for Vaccine R&D
-
Alfa Chemistry Releases Functional PEGs for Biological and Therapeutic Research
-
Protection Reagents Optimized to Facilitate Organic Synthesis at Alfa Chemistry
-
Rho Promotes Mark Ubert to CFO
Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has promoted Mark Ubert, MBA, to the position of Chief Financial Officer (CFO). As CFO, Mark will provide financial and strategic leadership to the growing organization, exemplified in the role he played in Rho’s acquisition of European CRO Dokumeds. Mark brings more than 30 years of experience to the role of Chief Financial Officer. He joined Rho in March of 2020 as VP of Finance.
Jan 16, 2022
-
Dolomite Bio announce launch of cost-effective Bioinformatics service with brand new RNAdia kit for single cell research
Dolomite Bio has announced the launch of a Bioinformatics Service which can be purchased alongside the recently launched RNAdia kit for single-cell research.
Jan 18, 2022
-
Flourish Research Adds Great Lakes Clinical Trials and Clinical Site Partners to the Network, Tripling Revenue and Expanding Clinical Expertise in Six Months
Great Lakes Clinical Trials and Clinical Site Partners join Excel Medical Clinical Trials and platform site Clinical Trials of Texas at Flourish Research, expanding capabilities to 60 indications.
Jan 19, 2022
-
Improved Image Quality and Resolution for all ZEISS Laser Scanning Microscopes
ZEISS LSM Plus and ZEISS Airyscan Joint Deconvolution introduced
Jan 19, 2022
-
Creative Bioarray Provides Reliable and Consistent FBS Products to Faciliatate The Research of Cell Culture
-
Creative Bioarray Launches A Wide Range of FISH Services to Support Detecting RNA and DNA Sequences